These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25495738)

  • 1. Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.
    Ali A; Sheikh IA; Mirza Z; Gan SH; Kamal MA; Abuzenadah AM; Damanhouri GA; Ashraf GM
    Curr Drug Metab; 2015; 16(5):376-88. PubMed ID: 25495738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications.
    Siafaka PI; Özcan Bülbül E; Dilsiz P; Karantas ID; Okur ME; Üstündağ Okur N
    J Drug Target; 2021 Jun; 29(5):476-490. PubMed ID: 33269637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology: Its Application in Treating Neurodegenerative Diseases.
    Naz F; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(1):34-53. PubMed ID: 32938356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.
    Benetti F; Gustincich S; Legname G
    Expert Opin Drug Discov; 2012 Mar; 7(3):245-59. PubMed ID: 22468955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.
    Masoudi Asil S; Ahlawat J; Guillama Barroso G; Narayan M
    Biomater Sci; 2020 Aug; 8(15):4109-4128. PubMed ID: 32638706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis.
    Shukla R; Singh A; Handa M; Flora SJS; Kesharwani P
    Drug Discov Today; 2021 Aug; 26(8):1972-1979. PubMed ID: 33892144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontier View on Nanotechnological Strategies for Neuro-therapy.
    Azhar A; Ashraf GM; Zia Q; Ansari SA; Perveen A; Hafeez A; Saeed M; Kamal MA; Alexiou A; Ganash M; Yarla NS; Baeesa SS; Alfiky MM; Bajouh OS
    Curr Drug Metab; 2018; 19(7):596-604. PubMed ID: 29512448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain drug delivery systems for neurodegenerative disorders.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2388-402. PubMed ID: 23016644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of Proteomics in Understanding Neurodegeneration.
    Pal R; Larsen JP; Moller SG
    Int Rev Neurobiol; 2015; 121():25-58. PubMed ID: 26315761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.
    Hoerndli F; David DC; Götz J
    Prog Neurobiol; 2005 Jun; 76(3):169-88. PubMed ID: 16169146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology.
    Kumar R; Aadil KR; Mondal K; Mishra YK; Oupicky D; Ramakrishna S; Kaushik A
    Crit Rev Biotechnol; 2022 Dec; 42(8):1180-1212. PubMed ID: 34823433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment.
    Asefy Z; Hoseinnejhad S; Ceferov Z
    Neurol Sci; 2021 Jul; 42(7):2653-2660. PubMed ID: 33846881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.
    Pehlivan SB
    Pharm Res; 2013 Oct; 30(10):2499-511. PubMed ID: 23959851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.